Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-09T13:24:22.928Z Has data issue: false hasContentIssue false

Right ventricular outflow tract stenting in children with tetralogy of Fallot beyond one year of age: indications and immediate outcomes

Published online by Cambridge University Press:  26 December 2024

Shaad Abqari*
Affiliation:
Department of Pediatrics, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Mohammad Moaaz Kidwai
Affiliation:
Department of Cardiology, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Mirza Mohammad Kamran
Affiliation:
Interdisciplinary Pediatric cardiac centre, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Mohammad Azam Haseen
Affiliation:
Department of CVTS, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
Shamayal Rabbani
Affiliation:
Department of CVTS, JNMCH, Aligarh Muslim University, Aligarh, Uttar Pradesh, India
*
Corresponding author: Shaad Abqari; Email: drshaadabqari@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Right ventricular outflow tract stenting has emerged as a key palliative intervention for infants with tetralogy of Fallot who are not suitable candidates for complete repair. Although the Blalock-Taussig shunt remains the standard palliative approach for tetralogy of Fallot patients over one year of age, the potential of right ventricular outflow tract stenting in this older age group has not been widely explored. In this study, we present our experience with right ventricular outflow tract stenting in children beyond one year of age.

Methods and Results:

In this study, a total of 52 patients of tetralogy of Fallot who underwent palliative stenting of the right ventricular outflow tract from 2018 to 2022 were enrolled. Out of the 52 patients, 38 children were more than 1 year of age with a mean age of 4.82 ± 3.5 (1.5–13 years) and mean weight of 13.10 ± 7.0 (5.6–34) kgs. Most common indication was presence of unfavourable anatomy in 27 (71%) followed by presence of refractory spells in 14 (36.8%) patients. Stent embolisation was seen in one patient, while two patients developed features of pulmonary oedema and needed prolonged ventilatory support. There was no mortality seen in this study group.

Conclusion:

Our study has shown that right ventricular outflow tract stenting in children even beyond one year of age is technically feasible, with good immediate outcomes, especially in those who present with any complication, thus reducing the perioperative morbidity and mortality.

Information

Type
Original Article
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Figure 1. Figure showing right ventricular (RV) angiogram. RV angiogram done using NIH catheter in LAO30/cranial30 view showing severe infundibular and valvular pulmonary stenosis with confluent and hypoplastic branch pulmonary arteries.

Figure 1

Figure 2. Figure showing stent being deployed with the support of long sheath (2a), guide catheter (2b) and without any support (2c). Figure 2a showing a long sheath being used to deploy the stent. Figure 2b showing guide catheter being used to deploy the stent. Figure 2c showing stent being deployed without the support of any sheath/catheter.

Figure 2

Figure 3. Figure showing check angiogram done via long sheath. Angiogram done via the long sheath in RAO30/cranial30 view, which was done post deployment, shows right ventricular outflow tract stent in proper position with relief of infundibular and valvular pulmonary stenosis.

Figure 3

Figure 4. Figure showing echo image after stent deployment. Colour doppler echo image in sub costal coronal view, showing right ventricular outflow tract stent in proper position covering the infundibular and valvular area.

Figure 4

Table 1. Table showing patient demographics

Figure 5

Table 2. Indication for right ventricular outflow tract stenting

Figure 6

Table 3. Table showing pulmonary arteries (PA) anatomy

Figure 7

Table 5. Table showing outcome and complications

Figure 8

Table 4. Shows the procedure-related hardware, techniques, and fluoroscopy time